Back to search

Article

Galectin-3 drives neuroinflammatory amyloid remodeling by stabilizing intermediate Aβ species and altering lysosomal processing

2025-03-17

Abstract excerpt

Neuroinflammation is a hallmark of Alzheimer’s disease (AD), yet the molecular mediators driving microglial dysfunction and neurotoxicity remain poorly understood. Here, we identify Galectin-3 (Gal3) as a central regulator of plaque-associated microglial responses, linking amyloid-beta (Aβ) aggregation, lysosomal function and plaque-associated neuritic damage. Using postmortem brain tissue from AD patients, we dem...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc208275-a544-5ea6-b002-879ab17dd1e4
DOI
10.1101/2025.03.17.643790
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Galectin-3 drives neuroinflammatory amyloid remodeling by stabilizing intermediate Aβ species and altering lysosomal processingDOI 10.1101/2025.03.17.643790
Select a neighboring publication to make it the new centre.